Compare · RGC vs SNDL
RGC vs SNDL
Side-by-side comparison of Regencell Bioscience Holdings Limited (RGC) and SNDL Inc. (SNDL): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RGC and SNDL operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $2.74B, about 7.7x SNDL ($356.6M).
- SNDL has hit the wire 2 times in the past 4 weeks while RGC has been quiet.
- SNDL has more recent analyst coverage (4 ratings vs 0 for RGC).
- Company
- Regencell Bioscience Holdings Limited
- SNDL Inc.
- Price
- -
- -
- Market cap
- $2.74B
- $356.6M
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2019
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 4
SNDL
SNDL Inc.
Sundial Growers Inc. engages in production and marketing of cannabis products for the adult-use market in Canada. It produces and distributes inhalable products, such as flower, pre-rolls, and vapes. The company offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. Sundial Growers Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.
Latest RGC
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
Latest SNDL
- SEC Form 6-K filed by SNDL Inc.
- SNDL Announces Successful Completion of EU-GMP Audit at Atholville Facility
- SEC Form 6-K filed by SNDL Inc.
- SNDL Reports Second Quarter 2026 Financial and Operational Results
- SEC Form 6-K filed by SNDL Inc.
- SEC Form 6-K filed by SNDL Inc.
- SNDL Announces Completion of Parallel Asset Acquisition and Positions for Nasdaq-Consolidated U.S. Medical Cannabis Operations
- SEC Form 6-K filed by SNDL Inc.
- SNDL to Report Second Quarter 2026 Financial Results on July 28, 2026
- SNDL Announces Update on Arrangement Agreement with 1CM for Acquisition of Ontario Cannabis Stores